Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Potential Equivalents of TET2 Mutations.
Pasca S, Jurj A, Zdrenghea M, Tomuleasa C. Pasca S, et al. Among authors: zdrenghea m. Cancers (Basel). 2021 Mar 24;13(7):1499. doi: 10.3390/cancers13071499. Cancers (Basel). 2021. PMID: 33805247 Free PMC article. Review.
Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy.
Petrushev B, Boca S, Simon T, Berce C, Frinc I, Dima D, Selicean S, Gafencu GA, Tanase A, Zdrenghea M, Florea A, Suarasan S, Dima L, Stanciu R, Jurj A, Buzoianu A, Cucuianu A, Astilean S, Irimie A, Tomuleasa C, Berindan-Neagoe I. Petrushev B, et al. Among authors: zdrenghea m. Int J Nanomedicine. 2016 Feb 15;11:641-60. doi: 10.2147/IJN.S94064. eCollection 2016. Int J Nanomedicine. 2016. PMID: 26929621 Free PMC article.
The use of rotation to fentanyl in cancer-related pain.
Dima D, Tomuleasa C, Frinc I, Pasca S, Magdo L, Berindan-Neagoe I, Muresan M, Lisencu C, Irimie A, Zdrenghea M. Dima D, et al. Among authors: zdrenghea m. J Pain Res. 2017 Feb 9;10:341-348. doi: 10.2147/JPR.S121920. eCollection 2017. J Pain Res. 2017. PMID: 28223843 Free PMC article.
Fibroblast dynamics as an in vitro screening platform for anti-fibrotic drugs in primary myelofibrosis.
Tomuleasa C, Selicean S, Gafencu G, Petrushev B, Pop L, Berce C, Jurj A, Trifa A, Rosu AM, Pasca S, Magdo L, Zdrenghea M, Dima D, Tanase A, Frinc I, Bojan A, Berindan-Neagoe I, Ghiaur G, Ciurea SO. Tomuleasa C, et al. Among authors: zdrenghea m. J Cell Physiol. 2018 Jan;233(1):422-433. doi: 10.1002/jcp.25902. Epub 2017 May 23. J Cell Physiol. 2018. PMID: 28294327
How to Diagnose and Treat a Cancer of Unknown Primary Site.
Tomuleasa C, Zaharie F, Muresan MS, Pop L, Fekete Z, Dima D, Frinc I, Trifa A, Berce C, Jurj A, Berindan-Neagoe I, Zdrenghea M. Tomuleasa C, et al. Among authors: zdrenghea m. J Gastrointestin Liver Dis. 2017 Mar;26(1):69-79. doi: 10.15403/jgld.2014.1121.261.haz. J Gastrointestin Liver Dis. 2017. PMID: 28338116 Free article. Review.
Minimal residual disease in chronic lymphocytic leukemia: A consensus paper that presents the clinical impact of the presently available laboratory approaches.
Tomuleasa C, Selicean C, Cismas S, Jurj A, Marian M, Dima D, Pasca S, Petrushev B, Moisoiu V, Micu WT, Vischer A, Arifeen K, Selicean S, Zdrenghea M, Bumbea H, Tanase A, Grewal R, Pop L, Aanei C, Berindan-Neagoe I. Tomuleasa C, et al. Among authors: zdrenghea m. Crit Rev Clin Lab Sci. 2018 Aug;55(5):329-345. doi: 10.1080/10408363.2018.1463508. Epub 2018 May 25. Crit Rev Clin Lab Sci. 2018. PMID: 29801428 Review.
Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndrome.
Jurj A, Pop L, Petrushev B, Pasca S, Dima D, Frinc I, Deak D, Desmirean M, Trifa A, Fetica B, Gafencu G, Selicean S, Moisoiu V, Micu WT, Berce C, Sacu A, Moldovan A, Colita A, Bumbea H, Tanase A, Dascalescu A, Zdrenghea M, Stiufiuc R, Leopold N, Tetean R, Burzo E, Tomuleasa C, Berindan-Neagoe I. Jurj A, et al. Among authors: zdrenghea m. Crit Rev Clin Lab Sci. 2018 Nov;55(7):501-515. doi: 10.1080/10408363.2018.1499707. Epub 2018 Sep 21. Crit Rev Clin Lab Sci. 2018. PMID: 30238808 Review.
104 results